| Aug 29 |
Vanda Pharmaceuticals Announces Participation in the Wells Fargo 2024 Healthcare Conference
|
| Aug 8 |
Vanda Pharmaceuticals: I Believe That The Bidding War Is Not Over
|
| Aug 2 |
Vanda Pharmaceuticals Inc. (VNDA) Q2 2024 Earnings Call Transcript
|
| Aug 1 |
Q2 2024 Vanda Pharmaceuticals Inc Earnings Call
|
| Jul 31 |
Vanda Pharmaceuticals GAAP EPS of -$0.08 beats by $0.13, revenue of $50.5M beats by $2.64M
|
| Jul 31 |
Vanda: Q2 Earnings Snapshot
|
| Jul 31 |
Vanda Pharmaceuticals Reports Second Quarter 2024 Financial Results
|
| Jul 30 |
Vanda Pharmaceuticals Q2 Earnings Preview
|
| Jul 26 |
Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024
|
| Jul 1 |
Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex
|
